1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
CSF and blood biomarkers for Parkinson's disease
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease : protocol for a systematic review and individual participant data meta-analysis
(
- Contribution to journal › Article
-
Mark
Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease
(
- Contribution to journal › Article
- 2016
-
Mark
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression
(
- Contribution to journal › Article
- 2015
-
Mark
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit.
2015) In Biological Psychiatry(
- Contribution to journal › Article
- 2013
-
Mark
Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism.
(
- Contribution to journal › Article
- 2011
-
Mark
Higher free d-aspartate and N-methyl-d-aspartate levels prevent striatal depotentiation and anticipate 1-DOPA-induced dyskinesia
(
- Contribution to journal › Article